Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 5, 2000, Pages 997-1001

  Wong, Johnson T ^a   Nagy, Catherine S ^a   Krinzman, Steven J ^a   MacLean, James A ^a   Bloch, Kurt J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Acetylsalicylic acid; Angioedema; Aspirin; Coronary artery disease; Desensitization; Nonsteroidal anti inflammatory drug; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; DESENSITIZATION; DRUG SAFETY; DRUG SENSITIVITY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; URTICARIA;

EID: 0034111162     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.104571     Document Type: Article

References (24)

1. 1. Vane JR, Botting RM. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med 1998;104:2-8S.
2. 2. Wu KKY. Biochemical pharmacology of nonsteroidal anti-inflammatory drugs. Biochem Pharmacol 1998;55:543-7.
3. 3. Kawai S, Nishida S, Kato M, Furumaya Y, Okamoto R, Koshino T, et al. Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells. Eur J Pharmacol 1998;347:87-94.
4. 4. Smith WL, Meade EA, DeWitt DL. Interactions of PGH synthase isozymes-1 and -2 with NSAIDs. Ann N Y Acad Sci 1994;744:50-7.
5. 5. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999;104:5-13.
6. 6. McEvoy GK, editor. AHFS drug information. American Society of Health-System Pharmacists; 1999.
7. 7. Cairns JA, Theroux P, Lewis HD Jr, Ezekowitz M, Meade TW, Sutton GC. Antithrombotic agents in coronary artery disease. Chest 1998;114:611-33S.
8. 8. Verstraete M. Primary and secondary prevention of arterial thromboembolism. Br Med Bull 1994;50:946-65.
9. 9. Stevenson DD, Simon RA. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs. In: Middleton E Jr, Ellis EF, Yunginger JW, Reed CE, Adkinson NF Jr, Busse WW, editors. Allergy principles and practice. 5th ed. St Louis: Mosby; 1998. p 1225-34.
10. 10. Grzelewska-Rzymowska I, Roznlecki J, Szmidt M. Aspirin "desensitization" in patients with aspirin-induced urticaria and angioedema. Allergol Immunopathol 1988;16:305-8.
11. 11. Asad SI, Kemeny DM, Youlten LJF, Frankland AW, Lessof MH. Effect of aspirin in "aspirin sensitive" patients. BMJ 1984;288:745-8.
12. 12. Stevenson DD. Challenge procedures in detection of reactions to aspirin and nonsteroidal anti-inflammatory drugs. Ann Allergy 1993;71:417-8.
13. 13. Wong JT, Ripple RE, MacLean JA, Marks DR, Bloch KJ. Vancomycin hypersensitivity: synergism with narcotics and "desensitization" by a rapid continuous intravenous protocol. J Allergy Clin Immunol 1994;94:189-94.
14. 14. Yosipovitch G, Rechavia E, Feinmesser M, David M. Adverse cutaneous reactions to ticlopidine in patients with coronary stents. J Am Acad Dermatol 1999;41:473-6.
15. 15. Chassany O, Narboux S, Thomas L, Cosson S, Caulin C. Quincke's edema during ticlopidine treatment. Presse Med 1999;28:18.
16. 16. Settipane GA, Pudupakkam RK. Aspirin intolerance, III: subtypes, familial occurrence, and cross-reactivity with tartrazine. J Allergy Clin Immunol 1975;56:215-21.
17. 17. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol 1977;60:276-84.
18. 18. Lee TH. Mechanism of bronchospasm in aspirin-sensitive asthma. Am Rev Respir Dis 1993;148:1442-3.
19. 19. Nasser SM, Pfister R, Christie PE, Sousa AR, Baker J, Schmitz-Schumann M, et al. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am J Respir Crit Care Med 1996;153:90-6.
20. 20. Cowburn AS, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik A, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998;101:834-46.
21. 21. Arm JP, O'Hickey SP, Spur BW, Lee TH. Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma. Am Rev Respir Dis 1989;140:148-53.
22. 22. Juergens UR, Christiansen SC, Stevenson DD, Zuraw BL. Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge. J Allergy Clin Immunol 1992;90:636-45.
23. 23. Blanca M, Perez E, Garcia JJ, Miranda A, Terrados S, Vega JM, et al. Angioedema and IgE antibodies to aspirin: a case report. Ann Allergy 1989;62:295-8.
24. 24. Zhu D, Becker WM, Schulz KH, Schubeler K, Schlaak M. The presence of specific IgE to salicyloyl and o-methylsalicyloyl in aspirin-sensitive patients. Asia Pac J Allergy Immunol 1992;10:25-32.